Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

UFOGBP

(UFOGBP)

Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
07/15/20242:36AMPR Newswire (US)Rivulis Appoints Irrigation Industry Veteran Joshua Dixon as CEO
07/15/20242:35AMBusiness WireLes produits Tineco en promotion sur Amazon durant les prime days le 16-17 juillet !
07/15/20242:35AMBusiness WireTineco Announces Exclusive Promotions for Amazon Prime Day 2024
07/15/20242:30AMGlobeNewswire Inc.Orderly Network Launches X Crypto Trading Championship to Energize Trading Community
07/15/20242:11AMPR Newswire (US)Third Plenum of the 20th CPC Central Committee has profound significance for both China and the world: Global Times editorial
07/15/20242:05AMGlobeNewswire Inc.Bango PLC ("Bango") Trading UpdateLSE:BGOBango Plc
07/15/20242:03AMBusiness WireFPT Announces New Chief Executive Officer for Chinese Subsidiary, Boosting Growth in the Trillion-Dollar Market
07/15/20242:01AMAlliance NewsAlliance NewsTOP NEWS: China industrial growth slows on year but picks up on month
07/15/20242:00AMGlobeNewswire Inc.Caledonia Mining Corporation Plc: Notification of relevant change to significant shareholderCMCL.LN
07/15/20242:00AMBusiness WireRavenna, città del mosaico, riconosciuta Patrimonio Mondiale dall’UNESCO, in collaborazione con EnChroma e Fondazione Paolina Brugnatelli permette ai visitatori daltonici di riscoprire i colori dei mosaici
07/15/20242:00AMGlobeNewswire Inc.Caledonia Mining Corporation Plc: Notification of relevant change to significant shareholderAMEX:CMCLCaledonia Mining Corporation Plc
07/15/20242:00AMGlobeNewswire Inc.AstraZeneca Closes Acquisition of Amolyt Pharma
07/15/20242:00AMGlobeNewswire Inc.Nyxoah Appoints Scott Holstine as Chief Commercial OfficerNASDAQ:NYXHNyxoah SA
07/15/20242:00AMGlobeNewswire Inc.Nyxoah Appoints Scott Holstine as Chief Commercial OfficerEU:NYXHNyxoah SA
07/15/20242:00AMGlobeNewswire Inc.Caledonia Mining Corporation Plc: Notification of relevant change to significant shareholderCMCL.L
07/15/20241:52AMPR Newswire (US)Rznomics Inc. Secures Australian Clinical Trial Notification for RHO-targeted Splicing Ribozyme-based RNA Editing Therapy for Retinitis Pigmentosa
07/15/20241:51AMAlliance NewsAlliance NewsLONDON MARKET EARLY CALL: Stocks called down; US political uncertainty
07/15/20241:49AMAlliance NewsAlliance NewsTOP NEWS: House prices ebb but political certainty could spur market
07/15/20241:48AMPR Newswire (US)Rznomics Inc. Secures Australian Clinical Trial Notification for RHO-targeted Splicing Ribozyme-based RNA Editing Therapy for Retinitis Pigmentosa
07/15/20241:47AMPR Newswire (US)CPHI & PMEC Shenzhen 2024: Fostering New Opportunities in Asia and China's Greater Bay Area
07/15/20241:46AMPR Newswire (US)The 26th China Beijing International High-Tech Expo Launches
07/15/20241:45AMBusiness WireHAMILTON GLOBAL OPPORTUNITIES : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITEEU:ALHGOHamilton Global Opportunities
07/15/20241:45AMPR Newswire (US)LG Water Solutions to Handle More Than 50% of Desalinated Water Capacity in Oman with a New SWRO Membrane Supply Contract
07/15/20241:31AMAlliance NewsAlliance NewsGET READY: Gore Street Energy, ME Group, Robert Walters at 0700 BST
07/15/20241:31AMAlliance NewsAlliance NewsAlliance News UK - start of day
07/15/20241:30AMBusiness WirePoxel Provides an Update on Its Financial Position for the Second Quarter and First Half of 2024 and Announces the Rescheduling of Its Annual General MeetingEU:POXELPoxel
07/15/20241:30AMGlobeNewswire Inc.Crossject to attend H.C. Wainwright 26th Annual Global Investment ConferenceEU:ALCJCrossject
07/15/20241:30AMBusiness WireSensorion Announces New Positive Secondary Efficacy Endpoints Data From SENS-401 Phase 2a Clinical Trial For The Preservation Of Residual Hearing LossEU:ALSENSensorion
07/15/20241:30AMBusiness WirePoxel fait le point sur sa situation financière pour les deuxième trimestre et premier semestre 2024 et annonce le report de son Assemblée Générale AnnuelleEU:POXELPoxel
07/15/20241:30AMBusiness WireSensorion annonce de nouvelles données positives concernant les critères secondaires d’efficacité de l’essai clinique de Phase 2a de SENS-401 dans la préservation de l’audition résiduelleEU:ALSENSensorion